The American Journal of Medicine
Volume 123, Issue 6 , Pages 479-480 , June 2010

The Risk of Stent Thrombosis after Coronary Arterial Stent Implantation

References 

  1. Alpert JS. The triumph of hope over experience. Am J Med. 2006;119:1003–1004
  2. Stone GW, Ellis SG, Colombo A, et al. Effect of prolonged thienopyridine use after drug eluting stent implantation (from the TAXUS Landmark Trials Data). Am J Cardiol. 2008;102:1017–1022
  3. Wenaweser P, Daemen J, Zwahlen M, et al. Incidence and correlates of stent thrombosis in routine clinical practice. J Am Coll Cardiol. 2008;52:1134–1140
  4. de la Torre-Hernandez JM, Alfonso F, Hernandez F, et al. Drug eluting stent thrombosis. J Am Coll Cardiol. 2008;51:986–990
  5. Doyle B, Rihal CS, O'Sullivan CJ, et al. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal stents. Circulation. 2007;116:2391–2398
  6. Windecker S, Meier B. Late coronary stent thrombosis. Circulation. 2007;116:1952–1965
  7. Airoldi F, Colombo A, Morici N, et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation. 2007;116:745–754
  8. Jaffe R, Strauss BH. Late and very late thrombosis of drug-eluting stents. J Am Coll Cardiol. 2007;50:119–127
  9. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol. 2007;49:2145–2150
  10. van Kuijk JP, Flu WJ, Schouten O, et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol. 2009;104:1229–1234
  11. Tanzilli G, Greco C, Pelliccia F, et al. Effectiveness of two year clopidogrel and aspirin in abolishing the risk of very late thrombosis after drug eluting stent implantation (from the TYCOON, Two Year ClOpidOgrel Need) study. Am J Cardiol. 2009;104:1357–1364
  12. Schulz S, Schuster T, Mehilli J, et al. Stent thrombosis after drug eluting stent implantation: incidence, timing and relation to discontinuation of clopidogrel therapy over a 4 year period. Eur Heart J. 2009;30:2714–2721
  13. Awata M, Kotani JI, Uematsu M, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation (Comparison with bare metal stents). Circulation. 2007;116:910–916
  14. Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;30:937–944
  15. Depta JP, Bhatt DL. Omeprazole and clopidogrel: should clinicians be worried?. Cleve Clin J Med. 2010;77:113–116

 Funding: None.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(10)00110-5

doi: 10.1016/j.amjmed.2010.02.007

The American Journal of Medicine
Volume 123, Issue 6 , Pages 479-480 , June 2010

Article Tools